ARCHIVES

Defying critics, von Eschenbach describes hands-on role at NCI while running FDA. NCI is unified behind 2015 goal, he says.

This article is from The Cancer Letter archive.

Vol. 31 No. 45 | December 9, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Workshop Not “A Formality,” Baines Responds To Kopans

November 19, 1993

NIH Open “One-Stop Shop” For Mutant Mouse Models.

July 20, 2001

Generic Drug Makers Set Sights In Taxol Worldwide Market

April 2, 1993

Avastin Improves Survival By 30 Percent In Advanced Non-Small Cell Lung Cancer

June 24, 2005

Healy Attacks Scripps-Sandoz Research Deal, Rep. Wyden Asks For HHS Investigation

March 19, 1993

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004